Home > Journals > Minerva Ginecologica > Past Issues > Minerva Ginecologica 2016 October;68(5) > Minerva Ginecologica 2016 October;68(5):536-43

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA GINECOLOGICA

A Journal on Obstetrics and Gynecology


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Scopus, Emerging Sources Citation Index


eTOC

 

REVIEWS  HEREDITARY GENITAL AND BREAST CANCER


Minerva Ginecologica 2016 October;68(5):536-43

Copyright © 2016 EDIZIONI MINERVA MEDICA

language: English

Risk-reducing surgery on the uterine adnexa: timing and type of surgical treatment, and pathology report

Mauro SIGNORELLI, Giorgio BOGANI, Antonino DITTO, Fabio MARTINELLI, Valentina CHIAPPA, Carlos LOPEZ, Cono SCAFFA, Domenica LORUSSO, Francesco RASPAGLIESI

Gynecologic Oncology Unit, National Cancer Institute, Milan, Italy


PDF  


Inherited mutations in BRCA1 and BRCA2 increase significantly the risk of developing breast and ovarian cancers, and they have been associated with increased risks of developing other types of cancer. Although screening programs have been implemented in order to detect cancers at the early stage, they resulted ineffective. To date, risk-reducing bilateral salpingo-oophorectomy represents the only procedure allowing reducing the incidence of ovarian cancer and increasing survival among BRCA1 and -2 mutation carriers. In the present review we will discuss the advantages and disadvantages related to the execution of prophylactic surgery, thus underlying possible beneficial and detrimental effects of this kind of surgery in premenopausal women. Additionally, we will investigate further therapeutic strategies aimed to reduce the risk of developing ovarian cancer, without affected patients’ hormonal status.

top of page

Publication History

Cite this article as

Corresponding author e-mail

giorgio.bogani@istitutotumori.mi.it